Industry Committee

The Industry Committee oversees the strategies and activities related to the industry and biotech members of the society. The committee aims to create networking, education and collaboration opportunities by providing a forum for those in industry to meet and discuss areas of interest that are particular to those involved in drug development and taking a product to market.


Kald Abdallah, MD, PhDBristol-Myers Squibb

Edward Cha, MD, PhDGenentech
Jennifer Gansert, MD, PhD - Amgen

Israel Lowy, MD, PhDRegeneron Pharmaceuticals

Giovanni Melillo, MD – AstraZeneca

Eric Rubin, MD - Merck & Co., Inc.